EFhd2 is a novel amyloid protein associated with pathological tau in Alzheimer's disease

Journal of Neurochemistry

Volumn 125, Issue 6, 2013, Pages 921-931

  Ferrer Acosta, Yancy ^a   Rodríguez Cruz, Eva N ^a   Orange, François ^a   De Jesús Cortés, Hector ^a   Madera, Bismark ^a   Vaquer Alicea, Jaime ^a   Ballester, Juan ^a   Guinel, Maxime J F ^a   Bloom, George S ^b   Vega, Irving E ^a  

^a UNIVERSITY OF PUERTO RICO   (Puerto Rico)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Alzheimer's disease; amyloid; calcium; EFhd2; tau; tauopathies

Indexed keywords

AMYLOID PRECURSOR PROTEIN; EF HAND DOMAIN CONTAINING PROTEIN 2; TAU PROTEIN; UNCLASSIFIED DRUG;

AGED; ALZHEIMER DISEASE; AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM BINDING; CARBOXY TERMINAL SEQUENCE; CIRCULAR DICHROISM; CLINICAL ARTICLE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; ELECTRON MICROSCOPY; HUMAN; HUMAN TISSUE; IMMUNOHISTOLOGY; IN VITRO STUDY; MALE; MOLECULAR PATHOLOGY; MOUSE; NEUROPATHOLOGY; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; STRUCTURE ANALYSIS;

ALZHEIMER DISEASE; AMYLOID; AMYLOIDOGENIC PROTEINS; ANIMALS; BRAIN; CALCIUM-BINDING PROTEINS; HUMANS; MICE; MICE, TRANSGENIC; NEUROFIBRILLARY TANGLES; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, TERTIARY; TAU PROTEINS;

EID: 84878761125     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12155     Document Type: Article

References (32)

1. Adams S. J., DeTure M. A., McBride M., Dickson D. W., and, Petrucelli L., (2010) Three repeat isoforms of tau inhibit assembly of four repeat tau filaments. PLoS ONE 5, e10810.
2. Botelho H. M., Leal S. S., Cardoso I., Yanamandra K., Morozova-Roche L. A., Fritz G., and, Gomes C. M., (2012) S100A6 amyloid fibril formation is calcium-modulated and enhances superoxide dismutase-1 (SOD1) aggregation. J. Biol. Chem. 287, 42233-42242.
3. Castellani R. J., Nunomura A., Lee H., Perry G., and, Smith M. A., (2008) Phosphorylated tau: toxic, protective, or none of the above. J. Alzheimers Dis. 14, 377-383.
4. Clinton L. K., Blurton-Jones M., Myczek K., Trojanowski J. Q., and, LaFerla F. M., (2010) Synergistic interactions between Abeta, tau, and alpha-synuclein: acceleration of neuropathology and cognitive decline. J. Neurosci. 30, 7281-7289.
5. Cohen T. J., Guo J. L., Hurtado D. E., Kwong L. K., Mills I. P., Trojanowski J. Q., and, Lee V. M., (2011) The acetylation of tau inhibits its function and promotes pathological tau aggregation. Nat. Commun. 2, 252.
6. Dütting S., Brachs S., and, Mielenz D., (2011) Fraternal twins: Swiprosin-1/EFhd2 and Swiprosin-2/EFhd1, two homologous EF-hand containing calcium binding adaptor proteins with distinct functions. Cell Commun. Signal. 9, 2-14.
7. Ferrer-Acosta Y., Rodríguez-Cruz E. N., Vaquer-Alicea A. C., and, Vega I. E., (2012) Functional and structural analysis of the conserved EFhd2 protein. Protein Peptide Let. Sep 4 [Epub ahead of print], PMID:22973849.
8. Friedhoff P., von Bergen M., Mandelkow E. M., Davies P., and, Mandelkow E., (1998) A nucleated assembly mechanism of Alzheimer paired helical filaments. Proc. Natl Acad. Sci. USA 95, 15712-15717.
9. García-Sierra F., Mondragón-Rodríguez S., and, Basurto-Islas G., (2008) Truncation of tau protein and its pathological significance in Alzheimer's disease. J. Alzheimers Dis. 14, 401-409.
10. Giasson B. I., Forman M. S., Higuchi M., Golbe L. I., Graves C. L., Kotzbauer P. T., Trojanowski J. Q., and, Lee V. M., (2003) Initiation and synergistic fibrillization of tau and alpha-synuclein. Science 300, 636-640.
11. Goedert M., Jakes R., Spillantini M. G., Hasegawa M., Smith M. J., and, Crowther R. A., (1996) Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans. Nature 383, 550-553.
12. Hagen S., Brachs S., Kroczek C., Fürnrohr B. G., Lang C., and, Mielenz D., (2012) The B cell receptor-induced calcium flux involves a calcium mediated positive feedback loop. Cell Calcium 51, 411-417.
13. Kolarova M., García-Sierra F., Bartos A., Ricny J., and, Ripova D., (2012) Structure and pathology of tau protein in Alzheimer disease. Int. J. Alzheimers Dis. 2012, 731526.
14. Kroczek C., Lang C., Brachs S., Grohmann M., Dütting S., Schweizer A., Nitschke L., Feller S. M., Jäck H. M., and, Mielenz D., (2010) Swiprosin-1/EFhd2 controls B cell receptor signaling through the assembly of the B cell receptor, Syk, and phospholipase C gamma2 in membrane rafts. J. Immunol. 184, 3665-3676.
15. Lasagna-Reeves C. A., Castillo-Carranza D. L., Sengupta U., Guerrero-Muñoz M. J., Kiritoshi T., Neugebauer V., Jackson G. R., and, Kayed R., (2012) Alzheimer brain-derived tau oligomers propagate pathology from endogenous tau. Sci. Rep. 2, 700.
16. Lee V. M. Y., Goedert M., and, Trojanowski J. Q., (2001) Neurodegenrative tauopathies. Annu. Rev. Neurosci. 24, 1121-1159.
17. Lee V. M., Brunden K. R., Hutton M., and, Trojanowski J. Q., (2011) Developing therapeutic approaches to tau, selected kinases, and related neuronal protein targets. Cold Spring Harb. Perspect. Med. 1, a006437.
18. Lewis J., McGowan E., Rockwood J., et al,. (2000) Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat. Genet. 25, 402-405.
19. Li H., Rahimi F., Sinha S., and, Murakami K., (2009) Amyloids and protein aggregation: analytical methods, in Encyclopedia of Analytical Chemistry (, Meyers R. A., ed.), pp. 1-32. John Wiley and Sons, UK.
20. Mandelkow E. M., and, Mandelkow E., (2012) Biochemistry and cell biology of tau protein in neurofibrillary degeneration. Cold Spring Harb. Perspect. Med. 2, a006247.
21. Mason J. M., and, Arndt K. M., (2004) Coiled coil domains: stability, specificity and biological implications. ChemBioChem 5, 170-176.
22. Mattson M. P., (2007) Calcium and neurodegeneration. Aging Cell 6, 337-350.
23. McAlinden A., Smith T. A., Sandell L. J., Ficheux D., Parry D. A. D., and, Hulmes D. J. S., (2003) α-Helical coiled-coil oligomerization domains are almost ubiquitous in the collagen superfamily. J. Biol. Chem. 43, 42200-42207.
24. Rankin C. A., Sun Q., and, Gamblin T. C., (2007) Tau phosphorylation by GSK-3beta promotes tangle-like filament morphology. Mol. Neurodegener. 28, 12.
25. Reinecke J. B., DeVos S. L., McGrath J. P., Shepard A. M., Goncharoff D. K., Tait D. N., Fleming S. R., Vincent M. P., and, Steinhilb M. L., (2011) Implicating calpain in tau-mediated toxicity in vivo. PLoS ONE 6, e23865.
26. Sahara N., Lewis J., DeTure M., McGowan E., Dickson D. W., Hutton M., and, Yen S. H., (2002) Assembly of tau in transgenic animals expressing P301L tau: alteration of phosphorylation and solubility. J. Neurochem. 83, 1498-1508.
27. SantaCruz K., Lewis J., Spires T., et al,. (2005) Tau suppression in a neurodegenerative mouse model improves memory function. Science 309, 476-481.
28. Vega I. E., Traverso E. E., Ferrer-Acosta Y., Matos E., Colon M., Gonzalez J., Dickson D., Hutton M., Lewis J., and, Yen S. H., (2008) A novel calcium binding protein is associated with tau proteins in tauopathy. J. Neurochem. 106, 96-106.
29. Vuadens F., Rufer N., Kress A., Corthésy P., Schneider P., and, Tissot J. D., (2004) Identification of swiprosin 1 in human lymphocytes. Proteomics 4, 2216-2220.
30. Wang J. Z., Grundke-Iqbal I., and, Iqbal K., (2007) Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration. Eur. J. Neurosci. 25, 59-68.
31. Wilson D. M., and, Binder L. I., (1997) Free fatty acids stimulate the polymerization of tau and amyloid beta peptides. Am. J. Pathol. 150, 2181-2195.
32. Zhukareva V., Shah K., Uryu K., Braak H., Del Tredici K., Sundarraj S., Clark C., Trojanowski J. Q., and, Lee V. M., (2002) Biochemical analysis of tau proteins in argyrophilic grain disease, Alzheimer's disease, and Pick's disease: a comparative study. Am. J. Pathol. 161, 1135-1141.